EUVIMEDEUVIMED entdecken
Crossref

Comparative value of HFpEF scores for risk stratification in patients with unexplained dyspnoea

Sebastiaan Dhont iD, Sara Moura-Ferreira, Youri Bekhuis iD, Maarten Falter, Mauricio Milani, Wouter L'Hoyes, Sarah Hoedemakers, Lucie Soens, Annemie Jacobs, Stephanie De Schutter, Rik Pauwels iD, Boris Delpire iD und 11 weitere

European Journal of Heart Failure · 09.03.2026

DOI: 10.1093/ejhf/xuag072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 09.03.2026. Verfasst von Sebastiaan Dhont und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In patients with unexplained dyspnoea, heart failure with preserved ejection fraction (HFpEF) is a frequent cause. Diagnostic scores estimate HFpEF probability, but their prognostic role and clinical applicability in this population remain uncertain. This study evaluated the association of HFpEF scores with structural remodelling, functional limitation, and clinical outcomes.

Methods

This multicentre cohort study included 2535 patients with unexplained dyspnoea who underwent combined cardiopulmonary exercise testing and echocardiography. HFpEF probability was assessed using H2FPEF, HFA-PEFF, and HFpEF-ABA scores, with patients stratified into risk categories.

Results

Higher scores correlated with adverse ventricular and atrial remodelling, impaired exercise capacity, and higher pulmonary pressures, both at rest and during exercise. Intermediate and high-risk categories for HFA-PEFF, H2FPEF, and HFpEF-ABA scores showed significantly elevated hazard ratios versus the low-risk group: HFA-PEFF (HR 2.62 95%CI 1.56–4.40, P < .001 and 5.49 95%CI 2.82–10.67, P = .005), H2FPEF (HR 2.74 95%CI 1.35–5.89, P < .001 and 6.21 95%CI 2.86–13.5, P < .001), and HFpEF-ABA (HR 1.28 95%CI .57–2.86, P = 0.549 and 2.50 95%CI 1.02–6.14, P = .046), all P < .001. Event rates increased stepwise across score categories, reaching 10 per 100 patient-years in the high-score groups. Score performance differed, particularly in the elderly, women, and those with atrial fibrillation. Incorporating echocardiographic parameters, particularly resting pulmonary pressure, improved HFpEF-ABA prognostic accuracy. In the NT-proBNP subgroup, functional criteria and NT-proBNP remained independent predictors for outcome.

Conclusions

HFpEF diagnostic scores reflect the structural and functional disease burden as well as clinical risk in unexplained dyspnoea. These scores are complementary and may enhance risk stratification.

Schlagwörter

Stichwörter der Autor:innen

CPETechoHFpEFdiagnostic scoresunexplained dyspnea

Autor:innen und Institutionen

  • Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • UHasselt, Faculty of Medicine and Life Sciences/LCRC, Diepenbeek, Belgium.
  • Jessa Hospital, Department of Cardiology and Jessa & Science, Hasselt, Belgium.
  • Department of Cardiovascular Sciences, UZ KU Leuven, Leuven, Belgium.
  • Department of Cardiology, Imelda Hospital, Bonheiden, Belgium.
  • Centre for Cardiovascular Diseases, University Hospital Brussels, Jette, Belgium.

ORCID-Profile: Sebastiaan Dhont, Youri Bekhuis, Rik Pauwels, Boris Delpire, Johan Verbeeck, Lieven Herbots, Philippe Debonnaire, Alexander Van De Bruaene

Zitieren

APA

Dhont, S., Moura-Ferreira, S., Bekhuis, Y., Falter, M., Milani, M., L'Hoyes, W., Hoedemakers, S., Soens, L., Jacobs, A., De Schutter, S., Pauwels, R., Delpire, B., Verbeeck, J., Jasaityte, R., Stassen, J., Herbots, L., Claessen, G., Gevaert, A. B., Debonnaire, P., …, & Verwerft, J. (2026). Comparative value of HFpEF scores for risk stratification in patients with unexplained dyspnoea. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag072

Vancouver

Dhont S, Moura-Ferreira S, Bekhuis Y, Falter M, Milani M, L'Hoyes W, et al. Comparative value of HFpEF scores for risk stratification in patients with unexplained dyspnoea. European Journal of Heart Failure. 2026. doi:10.1093/ejhf/xuag072

BibTeX
@article{Dhont2026,
  author = {Dhont, Sebastiaan and Moura-Ferreira, Sara and Bekhuis, Youri and Falter, Maarten and Milani, Mauricio and L'Hoyes, Wouter and Hoedemakers, Sarah and Soens, Lucie and Jacobs, Annemie and De Schutter, Stephanie and Pauwels, Rik and Delpire, Boris and Verbeeck, Johan and Jasaityte, Ruta and Stassen, Jan and Herbots, Lieven and Claessen, Guido and Gevaert, Andreas B and Debonnaire, Philippe and Van De Bruaene, Alexander and Verbrugge, Frederik H and Bertrand, Philippe B and Verwerft, Jan},
  title = {Comparative value of HFpEF scores for risk stratification in patients with unexplained dyspnoea},
  journal = {European Journal of Heart Failure},
  year = {2026},
  doi = {10.1093/ejhf/xuag072}
}
Kostenlos starten →